Tiltbio

Series-B+
tiltbio.com Biotech & Healthcare
Total Funding $25M
Latest Round $25M Series-B+
Last Announced May 13, 2025
Investors Undisclosed
Decision Makers 4 Verified

About Tiltbio

TILT Biotherapeutics is a clinical-stage biotechnology company creating the next generation of immunotherapies for solid tumors.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website tiltbio.com
Domain Registered Date May 30, 2013

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $25,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    Website domain registered

    tiltbio.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Tiltbio.

Funding History

1 Round
Series-B+ · May 13, 2025

Founders & Leadership

1

Akseli Hemminki

Founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts